Christos S. Mantzoros

78.5k total citations · 24 hit papers
642 papers, 56.4k citations indexed

About

Christos S. Mantzoros is a scholar working on Epidemiology, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Christos S. Mantzoros has authored 642 papers receiving a total of 56.4k indexed citations (citations by other indexed papers that have themselves been cited), including 276 papers in Epidemiology, 227 papers in Physiology and 198 papers in Endocrine and Autonomic Systems. Recurrent topics in Christos S. Mantzoros's work include Adipokines, Inflammation, and Metabolic Diseases (208 papers), Regulation of Appetite and Obesity (195 papers) and Adipose Tissue and Metabolism (145 papers). Christos S. Mantzoros is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (208 papers), Regulation of Appetite and Obesity (195 papers) and Adipose Tissue and Metabolism (145 papers). Christos S. Mantzoros collaborates with scholars based in United States, Greece and Italy. Christos S. Mantzoros's co-authors include Jean L. Chan, Stergios A. Pοlyzos, Jeffrey S. Flier, Μaria Dalamaga, Nikolaos Perakakis, Frank B. Hu, Alicja Wolk, Olivia M. Farr, Steven A. Shea and Michael F. Hilton and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Christos S. Mantzoros

635 papers receiving 55.1k citations

Hit Papers

Role of leptin in the neuroendocrine response to fasting 1996 2026 2006 2016 1996 2009 2018 2012 2018 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of leptin in the neuroendocrine response to fasting
    1996 2.6k citations Christos S. Mantzoros et al. profile →
  2. Adverse metabolic and cardiovascular consequences of circadian misalignment
    2009 1.7k citations Frank A. J. L. Scheer, Michael F. Hilton et al. Proceedings of the National Academy of Sciences profile →
  3. Obesity and cancer risk: Emerging biological mechanisms and perspectives
    2018 1.0k citations Christos S. Mantzoros et al. Metabolism profile →
  4. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise
    2012 872 citations Joo Young Huh, Mary Brinkoetter et al. Metabolism profile →
  5. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
    2018 849 citations Stergios A. Pοlyzos, Christos S. Mantzoros et al. Metabolism profile →
  6. Diabetes mellitus and risk of breast cancer: A meta‐analysis
    2007 669 citations Christos S. Mantzoros et al. profile →
  7. Mediterranean Diet and Incidence of and Mortality From Coronary Heart Disease and Stroke in Women
    2009 647 citations Christos S. Mantzoros et al. profile →
  8. Recombinant Human Leptin in Women with Hypothalamic Amenorrhea
    2004 639 citations Jean L. Chan, Christos S. Mantzoros et al. profile →
  9. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
    2020 566 citations Christos S. Mantzoros et al. Metabolism profile →
  10. Human leptin levels are pulsatile and inversely related to pituitary–ardenal function
    1997 507 citations Christos S. Mantzoros, George P. Chrousos et al. profile →
  11. The Role of Adiponectin in Cancer: A Review of Current Evidence
    2012 478 citations Christos S. Mantzoros et al. Endocrine Reviews profile →
  12. Physiology and role of irisin in glucose homeostasis
    2017 461 citations Nikolaos Perakakis, Joo Young Huh et al. profile →
  13. Leptin in human physiology and pathophysiology
    2011 438 citations Christos S. Mantzoros, Mary Brinkoetter et al. profile →
  14. Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome
    2013 428 citations Kyung‐Hee Park, Lesya Zaichenko et al. The Journal of Clinical Endocrinology & Metabolism profile →
  15. Non-alcoholic fatty liver disease and dyslipidemia: An update
    2016 422 citations Niki Katsiki, Christos S. Mantzoros et al. Metabolism profile →
  16. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
    2021 357 citations Vincent Wai‐Sun Wong, Rohit Loomba et al. profile →
  17. Cohort Profile: Project Viva
    2014 293 citations Christos S. Mantzoros et al. profile →
  18. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
    2023 257 citations Marlene Chakhtoura, Christos S. Mantzoros et al. profile →
  19. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
    2021 234 citations Christos S. Mantzoros et al. profile →
  20. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk
    2021 198 citations Christos S. Mantzoros et al. Metabolism profile →
  21. Inflammation in atherosclerosis: pathophysiology and mechanisms
    2024 89 citations Christos S. Mantzoros et al. profile →
  22. Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses
    2023 72 citations Christos S. Mantzoros et al. profile →
  23. Obesity and diabetes
    2023 70 citations Chrysoula Boutari, Christos S. Mantzoros et al. profile →
  24. The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation
    2024 47 citations Konstantinos Stefanakis, Christos S. Mantzoros et al. Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christos S. Mantzoros United States 123 21.3k 20.1k 15.7k 10.1k 9.7k 642 56.4k
Jeffrey S. Flier United States 137 28.4k 1.3× 19.8k 1.0× 25.4k 1.6× 22.6k 2.2× 12.5k 1.3× 314 80.7k
Rudolph L. Leibel United States 81 17.5k 0.8× 13.2k 0.7× 7.9k 0.5× 9.4k 0.9× 4.2k 0.4× 270 37.9k
Stephen O’Rahilly United Kingdom 108 16.2k 0.8× 9.8k 0.5× 14.4k 0.9× 16.7k 1.7× 5.8k 0.6× 429 46.8k
Gökhan S. Hotamışlıgil United States 105 24.3k 1.1× 29.9k 1.5× 5.6k 0.4× 26.3k 2.6× 8.1k 0.8× 178 71.9k
Yūji Matsuzawa Japan 123 25.2k 1.2× 36.8k 1.8× 8.8k 0.6× 16.7k 1.7× 13.5k 1.4× 700 80.5k
Iichiro Shimomura Japan 99 19.3k 0.9× 24.9k 1.2× 5.7k 0.4× 15.9k 1.6× 11.1k 1.1× 668 56.5k
Éric Ravussin United States 118 32.6k 1.5× 9.5k 0.5× 12.6k 0.8× 8.4k 0.8× 6.9k 0.7× 559 54.2k
Samuel Klein United States 104 23.6k 1.1× 12.7k 0.6× 3.9k 0.2× 11.9k 1.2× 10.3k 1.1× 383 48.5k
Philipp E. Scherer United States 135 31.5k 1.5× 32.5k 1.6× 8.2k 0.5× 26.9k 2.7× 6.4k 0.7× 503 74.4k
Tohru Funahashi Japan 102 23.1k 1.1× 37.0k 1.8× 8.8k 0.6× 10.1k 1.0× 7.9k 0.8× 337 55.5k

Countries citing papers authored by Christos S. Mantzoros

Since Specialization
Citations

This map shows the geographic impact of Christos S. Mantzoros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christos S. Mantzoros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christos S. Mantzoros more than expected).

Fields of papers citing papers by Christos S. Mantzoros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christos S. Mantzoros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christos S. Mantzoros. The network helps show where Christos S. Mantzoros may publish in the future.

Co-authorship network of co-authors of Christos S. Mantzoros

This figure shows the co-authorship network connecting the top 25 collaborators of Christos S. Mantzoros. A scholar is included among the top collaborators of Christos S. Mantzoros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christos S. Mantzoros. Christos S. Mantzoros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chakhtoura, Marlene, Nancy Nakhoul, Elie A. Akl, et al.. (2024). Oral vitamin D supplementation for adults with obesity undergoing bariatric surgery. Cochrane Database of Systematic Reviews. 2024(10). CD011800–CD011800. 2 indexed citations
3.
Angelidi, Angeliki M., Konstantinos Stefanakis, Sharon H. Chou, et al.. (2024). Relative Energy Deficiency in Sport (REDs): Endocrine Manifestations, Pathophysiology and Treatments. Endocrine Reviews. 45(5). 676–708. 18 indexed citations
4.
Demir, Münevver, Stefan R. Bornstein, Christos S. Mantzoros, & Nikolaos Perakakis. (2023). Liver fat as risk factor of hepatic and cardiometabolic diseases. Obesity Reviews. 24(10). e13612–e13612. 14 indexed citations
5.
Paz‐Graniel, Indira, Jesús García‐Gavilán, Emilio Ros, et al.. (2023). Adherence to the Mediterranean diet and nuclear magnetic resonance spectroscopy biomarkers in older individuals at high cardiovascular disease risk: cross-sectional and longitudinal analyses. American Journal of Clinical Nutrition. 119(1). 108–116. 2 indexed citations
6.
Mantzoros, Christos S., et al.. (2023). Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease. Therapeutics and Clinical Risk Management. Volume 19. 77–96. 30 indexed citations
7.
Danpanichkul, Pojsakorn, Cheng Han Ng, Mark Muthiah, et al.. (2023). The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis. Alimentary Pharmacology & Therapeutics. 58(10). 1062–1074. 17 indexed citations
8.
Kouvari, Matina, Thomas Tsiampalis, Christina Chrysohoou, et al.. (2022). Quality of plant-based diets in relation to 10-year cardiovascular disease risk: the ATTICA cohort study. European Journal of Nutrition. 61(5). 2639–2649. 18 indexed citations
9.
McGlinchey, Regina E., Catherine B. Fortier, Vasileios Lioutas, et al.. (2020). Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale. Contemporary Clinical Trials. 89. 105934–105934. 25 indexed citations
10.
Athyros, Vasilios G., Niki Katsiki, & Christos S. Mantzoros. (2017). Non-alcoholic fatty liver disease in South and South-east Asians living in Western Countries: a major health problem calling for action. Clinical Lipidology. 12(1). 40–42. 1 indexed citations
11.
Park, Kyung‐Hee, Lesya Zaichenko, Mary Brinkoetter, et al.. (2013). Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism. 98(12). 4899–4907. 428 indexed citations breakdown →
12.
Huffman, Derek M., Leonard H. Augenlicht, Xueying Zhang, et al.. (2013). Abdominal Obesity, Independent from Caloric Intake, Accounts for the Development of Intestinal Tumors in Apc1638N/+ Female Mice. Cancer Prevention Research. 6(3). 177–187. 31 indexed citations
13.
Moon, Hyun‐Seuk, John P. Chamberland, Konstantinos N. Aronis, Sofia Tseleni‐Balafouta, & Christos S. Mantzoros. (2011). Direct Role of Adiponectin and Adiponectin Receptors in Endometrial Cancer: In Vitro and Ex Vivo Studies in Humans. Molecular Cancer Therapeutics. 10(12). 2234–2243. 64 indexed citations
14.
Moragianni, Vasiliki A., Konstantinos N. Aronis, John P. Chamberland, & Christos S. Mantzoros. (2011). Short-Term Energy Deprivation Alters Activin A and Follistatin But Not Inhibin B Levels of Lean Healthy Women in a Leptin-Independent Manner. The Journal of Clinical Endocrinology & Metabolism. 96(12). 3750–3758. 15 indexed citations
15.
Scheer, Frank A. J. L., Michael F. Hilton, Christos S. Mantzoros, & Steven A. Shea. (2009). Adverse metabolic and cardiovascular consequences of circadian misalignment. Proceedings of the National Academy of Sciences. 106(11). 4453–4458. 1679 indexed citations breakdown →
16.
Mantzoros, Christos S.. (2009). Nutrition and metabolism : underlying mechanisms and clinical consequences. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 2 indexed citations
17.
Michalakis, Konstantinos, et al.. (2007). Serum Adiponectin Concentrations and Tissue Expression of Adiponectin Receptors Are Reduced in Patients with Prostate Cancer: A Case Control Study. Cancer Epidemiology Biomarkers & Prevention. 16(2). 308–313. 152 indexed citations
18.
Mantzoros, Christos S., Myrto Trakatelli, Helen Gogas, et al.. (2007). Circulating adiponectin levels in relation to melanoma: A case–control study. European Journal of Cancer. 43(9). 1430–1436. 29 indexed citations
19.
Chan, Jean L., et al.. (2005). Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin. Diabetologia. 49(1). 169–173. 51 indexed citations
20.
Moschos, Stergios J., Jean L. Chan, & Christos S. Mantzoros. (2002). Leptin and reproduction: a review. Fertility and Sterility. 77(3). 433–444. 394 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey S. Flier Breakdown of academic impact, for papers by Rudolph L. Leibel Breakdown of academic impact, for papers by Stephen O’Rahilly Breakdown of academic impact, for papers by Gökhan S. Hotamışlıgil Breakdown of academic impact, for papers by Yūji Matsuzawa Breakdown of academic impact, for papers by Iichiro Shimomura Breakdown of academic impact, for papers by Éric Ravussin Breakdown of academic impact, for papers by Samuel Klein Breakdown of academic impact, for papers by Philipp E. Scherer Breakdown of academic impact, for papers by Tohru Funahashi
Rankless by CCL
2026